Inr Tracking Coumadin Use With Phone App
NCT05715541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2023-02-08
Summary
This study aims to compare the INR values of the patients followed by face-to-face and telephone applications.
Conditions
- Warfarin
- Mobile Applications
Interventions
- OTHER
-
mobile applications with the name "Set My INR"
The relevant software company assisted in developing the phone application. The language of the application created with the name "Set My INR" is Turkish. The application provided an opportunity for patients to share and communicate with their physician after having the INR value measured in a health institution near their place of residence before coming to the hospital
Sponsors & Collaborators
-
Muhammed Onur Hanedan
lead OTHER
Principal Investigators
-
Muhammet Onur HANEDAN · MD, Associate Professor1
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-01
- Primary Completion
- 2022-11-30
- Completion
- 2022-11-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood
NCT01375725 ·Status: COMPLETED
-
Warfarin - How Good Are we at Maintaining Target Range ?
NCT01081327 ·Status: COMPLETED
-
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
NCT02376803 ·Status: COMPLETED ·Phase: PHASE4
-
AI-based Social Software to Manage wARfarin Therapy
NCT03870581 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation
NCT00621491 ·Status: COMPLETED ·Phase: NA
-
Genotype-Guided Warfarin Therapy Trial
NCT00904293 ·Status: COMPLETED ·Phase: NA
-
Enoxaparin in Acute Venous Thromboembolic Disease
NCT00265993 ·Status: COMPLETED ·Phase: PHASE4
-
Quality of Anticoagulation With Warfarin in Patient With Atrial Fibrillation for Secondary Stroke Prevention in Korea
NCT02810509 ·Status: COMPLETED
-
DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation
NCT00806624 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test
NCT04074980 ·Status: COMPLETED ·Phase: NA
-
Study to Test the Accuracy of a Prototype Handheld PT/INR Device
NCT01349712 ·Status: UNKNOWN
-
Assessment of 2012 Bioequivalence Standards for Warfarin
NCT02574754 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service
NCT02392104 ·Status: COMPLETED ·Phase: NA
-
Assessing the Ability of Warfarin Treated Patients to Predict Their INR
NCT02764112 ·Status: COMPLETED
-
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
NCT05794165 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
PT/INR Reference Interval IN Healthy Volunteers
NCT02319109 ·Status: COMPLETED
-
Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy
NCT04801329 ·Status: ACTIVE_NOT_RECRUITING
-
INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)
NCT04117048 ·Status: COMPLETED ·Phase: NA
-
PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care
NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4
-
Randomized Comparison of Warfarin Dosing Quality Between the Hamilton Nomogram and a Commercial Computer System
NCT01024452 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information
NCT00401414 ·Status: COMPLETED ·Phase: NA
-
The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma
NCT01050153 ·Status: COMPLETED ·Phase: NA
-
AntiCoagulation Tracking InterVention and Evaluation
NCT04059965 ·Status: WITHDRAWN ·Phase: NA
-
Differences in Coagulation Test Kits
NCT01109667 ·Status: COMPLETED
-
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
NCT01305148 ·Status: SUSPENDED ·Phase: NA